Market News & Trends

Elestrin Estradiol Gel to be Launched in US With LABLABO's Airless Metering Dispenser

Azur Pharma recently launched a new Hormonal Replacement Treatment (HRT) on the US market, Elestrin 0.06% Estradiol Gel. A close collaboration with this Irish lab allowed LABLABO to develop a high-performance airless pack using its latest technological advancements with the Airless Metering Dispenser, especially with the EasyFoil aluminium pouch that already won two international awards since its commercial launch: Alufoil Trophy 2009 and the Worldstar Award 2009 for Packaging Excellence.

Made of an aluminium and polyethylen multilayer foil, this new pouch ensures a maximum protection of the product inside against oxygen and UV rays. Its cylinder shape guarantees high restitution rates (up to 98% of the product delivered) and easy filling with basic equipment.

The metering pump delivers a constant and precise dose of 0.92 ml in a way that is necessary for this type of active ingredient. The sales package includes two 38-ml Sillage airless metering dispensers for a 2-month treatment.

This reference leads LABLABO to carry on its sales development strategy on the US market. It has dedicated regulatory support with Drug Master Files (DMFs) registered with the FDA for all of its products and a Quality Assurance organization suited to the pharmaceutical requirements of the Good Manufacturing Practices (GMPs) for which the company received the ISO 15378 certification in December 2010.

Total Page Views: 1589

Elestrin Estradiol Gel to be Launched in US With LABLABO's Airless Metering Dispenser

VIDEO SPOTLIGHT

COMPANY PROFILES

eBOOKS

INDUSTRY EVENTS